PowerPoint · PDF fileThe information in this presentation is current as of this date. ......

23

Transcript of PowerPoint · PDF fileThe information in this presentation is current as of this date. ......

Page 1: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 2: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 3: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 4: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 5: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 6: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 7: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 8: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 9: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 10: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 11: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 12: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 13: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 14: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 15: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 16: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 17: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 18: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 19: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 20: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 21: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 22: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 23: PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing

Erik Axl Sund: Varistyttö

Erik Axl Sund: Varistyttö

“HSP90 INHIBITION MEDIATED AXL RECEPTOR … Prakasam...The Tyrosine kinase receptor AXL belongs to the TAM (Tyro3, AXL and Mer) family, whose members are characterized by a highly

“HSP90 INHIBITION MEDIATED AXL RECEPTOR … Prakasam...The Tyrosine kinase receptor AXL belongs to the TAM (Tyro3, AXL and Mer) family, whose members are characterized by a highly

AXL BLOCKADE BY BGB324 INHIBITS BCR-ABL TYROSINE …...resistant cell line KCL-22 PonR. We analyzed the effects of genetic and pharmacologic Axl blockade by the small molecule Axl

AXL BLOCKADE BY BGB324 INHIBITS BCR-ABL TYROSINE …...resistant cell line KCL-22 PonR. We analyzed the effects of genetic and pharmacologic Axl blockade by the small molecule Axl

Revista Axl Arraiz

Revista Axl Arraiz

axl-rose (axl-rose@inbox.ru) · РОССИЙСКИЕ ХОЛДИНГИ. ЭКСПЕРТНЫЕ ПРОБЛЕМЫ ФОРМИРОВАНИЯ И ОБЕСПЕЧЕНИЯ РАЗВИТИЯ

axl-rose ([email protected]) · РОССИЙСКИЕ ХОЛДИНГИ. ЭКСПЕРТНЫЕ ПРОБЛЕМЫ ФОРМИРОВАНИЯ И ОБЕСПЕЧЕНИЯ РАЗВИТИЯ

AXL F UTH8 1F - media.digikey.com Sheets/Phoenix Contact PDFs/AXL... · for TC sensors (according to DIN EN 60584-3, IEC 60584-3, ... AXL F UTH8 1F PHOENIX CONTACT A-10... 8* AXL

AXL F UTH8 1F - media.digikey.com Sheets/Phoenix Contact PDFs/AXL... · for TC sensors (according to DIN EN 60584-3, IEC 60584-3, ... AXL F UTH8 1F PHOENIX CONTACT A-10... 8* AXL

SoliTherm - Axl Imperial

SoliTherm - Axl Imperial

Transmissions, Gearboxes and Axl e s

Transmissions, Gearboxes and Axl e s

Configuring VG224 Using AXL SQL Direct Queries [AXL THIN ... · VERSION: 03-01-2008 Configuring VG224 Using AXL SQL Direct Queries [AXL THIN API], Thick API [CM7]

Configuring VG224 Using AXL SQL Direct Queries [AXL THIN ... · VERSION: 03-01-2008 Configuring VG224 Using AXL SQL Direct Queries [AXL THIN API], Thick API [CM7]

Inscripcion parque explora axl y joestein

Inscripcion parque explora axl y joestein

AXL receptor tyrosine kinase - bergenbio.com€¦ · emerging technology Responder - Treat 30% Non Responder ¥ BerGenBio biomarker programme S el ct ing pa tien ts m ost likely to

AXL receptor tyrosine kinase - bergenbio.com€¦ · emerging technology Responder - Treat 30% Non Responder ¥ BerGenBio biomarker programme S el ct ing pa tien ts m ost likely to

BIOTECH WEBINAR - BerGenBio - Developing first-in-class ...

BIOTECH WEBINAR - BerGenBio - Developing first-in-class ...

Axl-8-100-WEB - CorkSport

Axl-8-100-WEB - CorkSport

BerGenBio presentation 06062017 - AksjeNorgeaksjenorge.no/wp-content/uploads/2017/06/BerGenBio-ved-Richard... · ADC program • Orphan designation ... Combination treatments are

BerGenBio presentation 06062017 - AksjeNorgeaksjenorge.no/wp-content/uploads/2017/06/BerGenBio-ved-Richard... · ADC program • Orphan designation ... Combination treatments are

Erik Axl Sund: Varjojen huone

Erik Axl Sund: Varjojen huone

Rencontre avec Axl Cendres

Rencontre avec Axl Cendres

ALTI PROFILI - AxL Spa

ALTI PROFILI - AxL Spa

Cancer R428, a Selective Small Molecule Inhibitor of Axl ...cancerres.aacrjournals.org/content/canres/70/4/1544.full.pdf · transcriptional regulator Snail. In support of an earlier

Cancer R428, a Selective Small Molecule Inhibitor of Axl ...cancerres.aacrjournals.org/content/canres/70/4/1544.full.pdf · transcriptional regulator Snail. In support of an earlier

Newborn Gallery: Ryan Axl Perez

Newborn Gallery: Ryan Axl Perez

AXL 02 Resonators

AXL 02 Resonators